Fnu Kaweeta, MD | |
877 Jefferson Ave, Memphis, TN 38103-2807 | |
(901) 448-6969 | |
Not Available |
Full Name | Fnu Kaweeta |
---|---|
Gender | Female |
Speciality | Hematology/oncology |
Experience | 21 Years |
Location | 877 Jefferson Ave, Memphis, Tennessee |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033421417 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 50258 (Tennessee) | Secondary |
207RH0003X | Internal Medicine - Hematology & Oncology | 50258 (Tennessee) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Methodist Healthcare Memphis Hospitals | Memphis, TN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ut Methodist Physicians Llc | 2769623669 | 71 |
News Archive
Investigational drug Abraxane™ (albumin nanoparticle paclitaxel), administered weekly without steroid premedication, is active and well tolerated in women with metastatic breast cancer whose disease had progressed while they were treated with paclitaxel (Taxol®) and/or docetaxel (Taxotere®).
When it comes to the emergence of antimalarial drug resistance, it's not a question of 'if' but 'when'. In order to keep up with the quickly evolving Plasmodium parasite - the cause of malaria - new ways to treat and control the disease must be found.
Has tooth brushing frequency improved among children and adolescents? At what age is occupational therapy most commonly used? How many girls have been vaccinated against Human papillomavirus (HPV)? What influence does social status have on the utilization of medical services?
Two janus kinase (JAK) inhibitors are substantially improving treatment of myelofibrosis in patients, say Mayo Clinic researchers who are presenting results of several clinical trials at the 52nd annual meeting of the American Society of Hematology (ASH) Dec. 4 in Orlando.
Dr. Jeffrey L. Cummings, UNLV research professor and a leading expert on Alzheimer's disease clinical trials, led a five-year review of all Alzheimer's drugs in the development pipeline. He says today there is more hope than ever that we'll one day solve Alzheimer's.
› Verified 1 days ago
Entity Name | Methodist Inpatient Physicians Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1609850692 PECOS PAC ID: 1254241235 Enrollment ID: O20050815000700 |
News Archive
Investigational drug Abraxane™ (albumin nanoparticle paclitaxel), administered weekly without steroid premedication, is active and well tolerated in women with metastatic breast cancer whose disease had progressed while they were treated with paclitaxel (Taxol®) and/or docetaxel (Taxotere®).
When it comes to the emergence of antimalarial drug resistance, it's not a question of 'if' but 'when'. In order to keep up with the quickly evolving Plasmodium parasite - the cause of malaria - new ways to treat and control the disease must be found.
Has tooth brushing frequency improved among children and adolescents? At what age is occupational therapy most commonly used? How many girls have been vaccinated against Human papillomavirus (HPV)? What influence does social status have on the utilization of medical services?
Two janus kinase (JAK) inhibitors are substantially improving treatment of myelofibrosis in patients, say Mayo Clinic researchers who are presenting results of several clinical trials at the 52nd annual meeting of the American Society of Hematology (ASH) Dec. 4 in Orlando.
Dr. Jeffrey L. Cummings, UNLV research professor and a leading expert on Alzheimer's disease clinical trials, led a five-year review of all Alzheimer's drugs in the development pipeline. He says today there is more hope than ever that we'll one day solve Alzheimer's.
› Verified 1 days ago
Entity Name | Southeastern Physician Services Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1083835441 PECOS PAC ID: 0042307852 Enrollment ID: O20071025000571 |
News Archive
Investigational drug Abraxane™ (albumin nanoparticle paclitaxel), administered weekly without steroid premedication, is active and well tolerated in women with metastatic breast cancer whose disease had progressed while they were treated with paclitaxel (Taxol®) and/or docetaxel (Taxotere®).
When it comes to the emergence of antimalarial drug resistance, it's not a question of 'if' but 'when'. In order to keep up with the quickly evolving Plasmodium parasite - the cause of malaria - new ways to treat and control the disease must be found.
Has tooth brushing frequency improved among children and adolescents? At what age is occupational therapy most commonly used? How many girls have been vaccinated against Human papillomavirus (HPV)? What influence does social status have on the utilization of medical services?
Two janus kinase (JAK) inhibitors are substantially improving treatment of myelofibrosis in patients, say Mayo Clinic researchers who are presenting results of several clinical trials at the 52nd annual meeting of the American Society of Hematology (ASH) Dec. 4 in Orlando.
Dr. Jeffrey L. Cummings, UNLV research professor and a leading expert on Alzheimer's disease clinical trials, led a five-year review of all Alzheimer's drugs in the development pipeline. He says today there is more hope than ever that we'll one day solve Alzheimer's.
› Verified 1 days ago
Entity Name | Ut Methodist Physicians Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1427317908 PECOS PAC ID: 2769623669 Enrollment ID: O20130718000263 |
News Archive
Investigational drug Abraxane™ (albumin nanoparticle paclitaxel), administered weekly without steroid premedication, is active and well tolerated in women with metastatic breast cancer whose disease had progressed while they were treated with paclitaxel (Taxol®) and/or docetaxel (Taxotere®).
When it comes to the emergence of antimalarial drug resistance, it's not a question of 'if' but 'when'. In order to keep up with the quickly evolving Plasmodium parasite - the cause of malaria - new ways to treat and control the disease must be found.
Has tooth brushing frequency improved among children and adolescents? At what age is occupational therapy most commonly used? How many girls have been vaccinated against Human papillomavirus (HPV)? What influence does social status have on the utilization of medical services?
Two janus kinase (JAK) inhibitors are substantially improving treatment of myelofibrosis in patients, say Mayo Clinic researchers who are presenting results of several clinical trials at the 52nd annual meeting of the American Society of Hematology (ASH) Dec. 4 in Orlando.
Dr. Jeffrey L. Cummings, UNLV research professor and a leading expert on Alzheimer's disease clinical trials, led a five-year review of all Alzheimer's drugs in the development pipeline. He says today there is more hope than ever that we'll one day solve Alzheimer's.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Fnu Kaweeta, MD 46 N Arcadian Cir Apt 104, Memphis, TN 38103-5976 Ph: (901) 730-9588 | Fnu Kaweeta, MD 877 Jefferson Ave, Memphis, TN 38103-2807 Ph: (901) 448-6969 |
News Archive
Investigational drug Abraxane™ (albumin nanoparticle paclitaxel), administered weekly without steroid premedication, is active and well tolerated in women with metastatic breast cancer whose disease had progressed while they were treated with paclitaxel (Taxol®) and/or docetaxel (Taxotere®).
When it comes to the emergence of antimalarial drug resistance, it's not a question of 'if' but 'when'. In order to keep up with the quickly evolving Plasmodium parasite - the cause of malaria - new ways to treat and control the disease must be found.
Has tooth brushing frequency improved among children and adolescents? At what age is occupational therapy most commonly used? How many girls have been vaccinated against Human papillomavirus (HPV)? What influence does social status have on the utilization of medical services?
Two janus kinase (JAK) inhibitors are substantially improving treatment of myelofibrosis in patients, say Mayo Clinic researchers who are presenting results of several clinical trials at the 52nd annual meeting of the American Society of Hematology (ASH) Dec. 4 in Orlando.
Dr. Jeffrey L. Cummings, UNLV research professor and a leading expert on Alzheimer's disease clinical trials, led a five-year review of all Alzheimer's drugs in the development pipeline. He says today there is more hope than ever that we'll one day solve Alzheimer's.
› Verified 1 days ago
Khawaja Muhammad Muddassir, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1325 Eastmoreland Ave, Suite 370, Memphis, TN 38104 Phone: 901-758-7888 Fax: 901-387-5153 | |
Allison Montague, Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1955 S 3rd St, Memphis, TN 38109 Phone: 901-515-5800 | |
Dr. Marcia Bradford, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 360 E Eh Crump Blvd, Memphis, TN 38126 Phone: 901-261-2000 Fax: 901-946-9262 | |
Dr. Aleksandar Jankov, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 6029 Walnut Grove Rd, Suite 301, Memphis, TN 38120 Phone: 901-747-9081 Fax: 901-747-9087 | |
Manoj K Jain, MD, MPH Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 6029 Walnut Grove Rd Ste 209, Memphis, TN 38120 Phone: 901-681-0778 Fax: 901-821-9987 | |
Dr. Karl Weber, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 880 Madison Ave, Memphis, TN 38103 Phone: 901-545-6969 Fax: 901-545-4739 | |
Dr. Pedro Velasquez, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1068 Cresthaven Rd Ste 300, Memphis, TN 38119 Phone: 901-683-0024 Fax: 901-683-0086 |